FIGS (FIGS) to Release Earnings on Thursday

FIGS (NYSE:FIGS) is projected to issue its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $153.1450 million for the quarter. Parties can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:00 PM ET.

FIGS (NYSE:FIGS) last posted its quarterly earnings data on Thursday, February 26th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.08. The business had revenue of $201.90 million during the quarter, compared to the consensus estimate of $165.33 million. FIGS had a net margin of 5.43% and a return on equity of 8.41%. FIGS’s quarterly revenue was up 33.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.01 EPS. On average, analysts expect FIGS to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

FIGS Price Performance

Shares of NYSE FIGS traded down $0.15 during trading hours on Wednesday, hitting $14.40. 571,567 shares of the stock were exchanged, compared to its average volume of 3,259,970. The company’s 50 day moving average is $14.92 and its 200 day moving average is $12.00. The firm has a market capitalization of $2.40 billion, a P/E ratio of 75.56 and a beta of 1.12. FIGS has a one year low of $4.25 and a one year high of $17.48.

Insider Buying and Selling at FIGS

In other FIGS news, CEO Catherine Eva Spear sold 62,335 shares of the firm’s stock in a transaction dated Thursday, April 2nd. The shares were sold at an average price of $14.44, for a total value of $900,117.40. Following the completion of the sale, the chief executive officer owned 1,794,964 shares in the company, valued at approximately $25,919,280.16. This trade represents a 3.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sarah Oughtred sold 10,872 shares of the firm’s stock in a transaction dated Thursday, April 2nd. The shares were sold at an average price of $14.44, for a total transaction of $156,991.68. Following the completion of the sale, the chief financial officer owned 1,153,388 shares of the company’s stock, valued at $16,654,922.72. The trade was a 0.93% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 675,098 shares of company stock worth $10,912,375. 29.44% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On FIGS

Several hedge funds and other institutional investors have recently added to or reduced their stakes in FIGS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of FIGS by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 77,219 shares of the company’s stock valued at $354,000 after purchasing an additional 3,276 shares during the last quarter. Woodline Partners LP bought a new position in shares of FIGS in the 1st quarter valued at about $3,199,000. Creative Planning boosted its stake in FIGS by 181.3% during the 2nd quarter. Creative Planning now owns 65,740 shares of the company’s stock worth $371,000 after acquiring an additional 42,367 shares during the last quarter. Prudential Financial Inc. bought a new position in FIGS during the 2nd quarter worth approximately $70,000. Finally, Russell Investments Group Ltd. increased its stake in FIGS by 102.4% in the second quarter. Russell Investments Group Ltd. now owns 147,440 shares of the company’s stock valued at $832,000 after purchasing an additional 74,578 shares in the last quarter. Institutional investors and hedge funds own 92.21% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on FIGS shares. Oppenheimer raised shares of FIGS from a “market perform” rating to an “outperform” rating and set a $22.00 price target for the company in a report on Friday, March 20th. Barclays raised shares of FIGS from a “hold” rating to a “strong-buy” rating in a report on Friday, February 27th. Morgan Stanley increased their price objective on shares of FIGS from $8.00 to $15.00 and gave the company an “equal weight” rating in a research note on Monday, April 13th. The Goldman Sachs Group upgraded shares of FIGS from a “strong sell” rating to a “hold” rating in a research note on Friday, February 27th. Finally, Wall Street Zen upgraded shares of FIGS from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 28th. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $15.93.

About FIGS

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.